Your browser is no longer supported. Please, upgrade your browser.
Settings
IDXX IDEXX Laboratories, Inc. daily Stock Chart
IDXX [NASD]
IDEXX Laboratories, Inc.
IndexS&P 500 P/E58.67 EPS (ttm)3.08 Insider Own1.30% Shs Outstand86.43M Perf Week4.45%
Market Cap15.64B Forward P/E49.37 EPS next Y3.67 Insider Trans-18.63% Shs Float85.68M Perf Month14.97%
Income277.30M PEG2.90 EPS next Q0.73 Inst Own- Short Float1.65% Perf Quarter11.99%
Sales1.91B P/S8.21 EPS this Y19.10% Inst Trans0.17% Short Ratio2.69 Perf Half Y8.60%
Book/sh-0.56 P/B- EPS next Y13.29% ROA17.30% Target Price149.89 Perf Year52.21%
Cash/sh5.25 P/C34.44 EPS next 5Y20.24% ROE-349.40% 52W Range116.54 - 180.88 Perf YTD15.71%
Dividend- P/FCF55.19 EPS past 5Y11.90% ROI25.00% 52W High0.04% Beta0.52
Dividend %- Quick Ratio0.80 Sales past 5Y7.80% Gross Margin55.90% 52W Low55.27% ATR3.11
Employees7365 Current Ratio0.90 Sales Q/Q9.70% Oper. Margin20.90% RSI (14)82.49 Volatility1.68% 1.92%
OptionableYes Debt/Eq- EPS Q/Q27.50% Profit Margin14.50% Rel Volume0.85 Prev Close180.63
ShortableYes LT Debt/Eq- EarningsFeb 01 BMO Payout0.00% Avg Volume525.31K Price180.95
Recom2.10 SMA209.34% SMA5013.60% SMA20013.08% Volume445,005 Change0.18%
Jan-16-18Initiated Piper Jaffray Overweight $200
Aug-23-17Upgrade BofA/Merrill Neutral → Buy
Jul-28-17Upgrade CL King Neutral → Buy
Feb-03-17Downgrade Feltl & Co. Hold → Sell
Sep-29-16Resumed BofA/Merrill Neutral
Aug-16-16Reiterated Stifel Buy $120 → $125
Aug-03-16Upgrade Northcoast Sell → Neutral
Jul-20-16Reiterated Canaccord Genuity Buy $90 → $98
Apr-19-16Reiterated Canaccord Genuity Buy $80 → $85
Apr-01-16Initiated CL King Neutral
Mar-21-16Reiterated Stifel Buy $80 → $85
Feb-04-16Initiated Credit Suisse Outperform
Oct-29-15Reiterated Stifel Buy $85 → $80
Aug-28-15Downgrade Raymond James Outperform → Mkt Perform
Aug-13-15Reiterated Stifel Buy $78 → $85
Jul-23-15Reiterated Canaccord Genuity Buy $80 → $75
Apr-29-15Reiterated Stifel Buy $178 → $155
Jan-22-15Reiterated Canaccord Genuity Buy $160 → $175
Jan-16-15Reiterated Stifel Buy $155 → $178
Dec-10-14Reiterated Canaccord Genuity Buy $153 → $160
Jan-18-18 02:59PM  IDEXX Laboratories to Release 2017 Fourth Quarter and Full-Year Financial Results PR Newswire
Jan-17-18 03:00AM  Stocks With Rising Relative Strength: Idexx Laboratories Investor's Business Daily
Jan-16-18 08:07AM  See what the IHS Markit Score report has to say about Idexx Laboratories Inc. Markit
Jan-15-18 09:28AM  IDEXX Launches Catalyst SDMA for Veterinary Renal Disorder Zacks
Jan-11-18 07:15PM  Idexx Laboratories Inc (IDXX) Chairman, President & CEO Jonathan W Ayers Sold $9 million of ... GuruFocus.com
Jan-09-18 08:08AM  See what the IHS Markit Score report has to say about Idexx Laboratories Inc. Markit
Jan-08-18 08:00AM  IDEXX to Introduce Applied BioCodes Innovative Multiplex Technology Across Global Reference Laboratory Network Business Wire
07:32AM  IDEXX Launches SDMA in the Point of Care with IDEXX Catalyst® SDMA Test PR Newswire
Jan-05-18 08:20AM  Recent Analysis Shows Chimerix, Highwoods Properties, HubSpot, Biglari, IDEXX Laboratories, and Argan Market Influences Renewed Outlook, Key Drivers of Growth GlobeNewswire
07:00AM  IDEXX Laboratories Announces Estimated Impact of U.S. Tax Reform PR Newswire
Jan-02-18 03:48PM  IDEXX Laboratories to Present at J.P. Morgan Healthcare Conference PR Newswire
Jan-01-18 07:45AM  IDEXX Laboratories, Inc. breached its 50 day moving average in a Bearish Manner : IDXX-US : January 1, 2018 Capital Cube
Dec-20-17 12:30PM  6 MedTech Stocks Set to Crush the Market in 2018 Zacks
Dec-19-17 08:05AM  Ecolab, Cargill and Techstars Launch Accelerator Program Zacks
Dec-15-17 08:02AM  IDEXX Laboratories, Inc. breached its 50 day moving average in a Bearish Manner : IDXX-US : December 15, 2017 Capital Cube
Dec-11-17 08:08AM  See what the IHS Markit Score report has to say about Idexx Laboratories Inc. Markit
Dec-08-17 01:04PM  ETFs with exposure to IDEXX Laboratories, Inc. : December 8, 2017 Capital Cube
Dec-07-17 07:50AM  Free Research Report as IDEXX Laboratories Revenue Grew 9.7% and EPS Surged 27.4% ACCESSWIRE
Dec-06-17 12:13PM  IDEXX Laboratories, Inc. Value Analysis (NASDAQ:IDXX) : December 6, 2017 Capital Cube
08:18AM  Here's Why You Should Invest in PetMed (PETS) Stock Now Zacks
08:08AM  See what the IHS Markit Score report has to say about Idexx Laboratories Inc. Markit
Dec-05-17 03:43PM  Edited Transcript of IDXX earnings conference call or presentation 31-Oct-17 12:30pm GMT Thomson Reuters StreetEvents
07:18AM  IDEXX Laboratories, Inc. breached its 50 day moving average in a Bullish Manner : IDXX-US : December 5, 2017 Capital Cube
Dec-04-17 08:19AM  Zacks.com highlights: Chemed, Baxter International, IDEXX Laboratories, Advanced Energy Industries and Pioneer Natural Resources Zacks
Dec-01-17 08:53AM  5 of the Most Efficient Stocks to Boost Your Portfolio Zacks
08:08AM  See what the IHS Markit Score report has to say about Idexx Laboratories Inc. Markit
Nov-30-17 07:11PM  Cramer Remix: Amazon may not be as powerful as it seems CNBC Videos
06:58PM  Idexx Laboratories CEO: 'Blockbuster' pet care technology... CNBC Videos
Nov-29-17 08:42AM  Looking for a Growth Stock? Why It is Time to Focus on IDEXX Laboratories (IDXX) Zacks
Nov-28-17 06:47AM  The Zacks Analyst Blog Highlights: IDEXX Laboratories, Luminex, Masimo, Align Technology and Cooper Companies Zacks
Nov-27-17 02:13PM  ETFs with exposure to IDEXX Laboratories, Inc. : November 27, 2017 Capital Cube
12:30PM  5 MedTech Stocks to Beat Tax Hazards With Positive Returns Zacks
08:06AM  See what the IHS Markit Score report has to say about Idexx Laboratories Inc. Markit
Nov-24-17 08:07AM  See what the IHS Markit Score report has to say about Idexx Laboratories Inc. Markit
Nov-22-17 01:08PM  The 3 Stocks on the MFM Team's Radar This Week Motley Fool
Nov-20-17 08:07AM  See what the IHS Markit Score report has to say about Idexx Laboratories Inc. Markit
Nov-16-17 08:43AM  Accelerate Diagnostics (AXDX) in Focus: Stock Moves 6.7% Higher Zacks
07:40AM  Zacks.com highlights: Home Depot, Baxter International, IDEXX Laboratories, NVR and MAM Software Group Zacks
Nov-15-17 07:13PM  Cramer's lightning round: Don't buy Mallinckrodt after it... CNBC Videos
08:23AM  5 of the Most Efficient Stocks to Buy Now Zacks
08:08AM  See what the IHS Markit Score report has to say about Idexx Laboratories Inc. Markit
Nov-14-17 06:49PM  Cramer's lightning round: This is your chance to get into 'up stock' Idexx Labs CNBC
10:14AM  4 Top Growth Picks to Avoid Tax Tangle in MedTech Zacks
08:08AM  See what the IHS Markit Score report has to say about Idexx Laboratories Inc. Markit
Nov-13-17 12:33PM  ETFs with exposure to IDEXX Laboratories, Inc. : November 13, 2017 Capital Cube
Nov-03-17 12:14PM  ETFs with exposure to IDEXX Laboratories, Inc. : November 3, 2017 Capital Cube
08:37AM  IDEXX Laboratories, Inc. breached its 50 day moving average in a Bearish Manner : IDXX-US : November 3, 2017 Capital Cube
Nov-02-17 04:47PM  IDEXX Laboratories, Inc. Puts Long-Term Profits Ahead of Short-Term Revenue Motley Fool
09:57AM  IDEXX Laboratories, Inc. :IDXX-US: Earnings Analysis: Q3, 2017 By the Numbers : November 2, 2017 Capital Cube
Nov-01-17 03:00AM  Stocks To Watch: Idexx Laboratories Sees RS Rating Jump To 83 Investor's Business Daily
Oct-31-17 12:18PM  IDEXX Laboratories (IDXX) Q3 Earnings Beat, Revenues Miss Zacks
08:23AM  IDEXX Laboratories (IDXX) Beats on Q3 Earnings, View Up Zacks
07:35AM  IDEXX Laboratories Inc (IDXX): Is It A Good Long Term Opportunity? Simply Wall St.
07:21AM  Idexx beats 3Q profit forecasts Associated Press
07:00AM  The Humanization of Pets Has Changed the World -- Here's the Best Stock Pick TheStreet.com
07:00AM  IDEXX Laboratories Announces Third Quarter Results PR Newswire
Oct-27-17 08:36AM  Should You Buy IDEXX Laboratories (IDXX) Ahead of Earnings? Zacks
03:00AM  Stocks To Watch: Idexx Laboratories Sees Relative Strength Rating Rise To 81 Investor's Business Daily
03:00AM  Earnings Season Preview: Idexx Laboratories Near Buy Zone With Quarterly Report Due Investor's Business Daily
Oct-26-17 08:08AM  See what the IHS Markit Score report has to say about Idexx Laboratories Inc. Markit
Oct-24-17 08:07AM  See what the IHS Markit Score report has to say about Idexx Laboratories Inc. Markit
Oct-23-17 09:07AM  Can Companion Animal Group Drive IDEXX's (IDXX) Q3 Earnings? Zacks
Oct-19-17 08:06AM  See what the IHS Markit Score report has to say about Idexx Laboratories Inc. Markit
Oct-17-17 09:11AM  Phibro Animal Banks on Diverse Portfolio, Competition Rife Zacks
09:10AM  Henry Schein (HSIC) Inks Distribution Agreement with Terason Zacks
Oct-16-17 10:13AM  Here's Why You Should Buy Thermo Fisher Scientific (TMO) Now Zacks
07:58AM  Here's Why Investors Should Buy Integra LifeSciences Now Zacks
07:57AM  TransEnterix Senhance Surgical Robotic System Wins FDA Nod Zacks
Oct-13-17 09:41AM  Henry Schein Gains on Strategic Buyouts, Cost Concern a Woe Zacks
09:03AM  NuVasive's (NUVA) PRECICE System Gets Expanded FDA Approval Zacks
08:46AM  Here's Why Investors Should Sell Ecolab (ECL) Right Away Zacks
08:42AM  Abbott Banks on FDA Approvals and Buyouts, Competition Rife Zacks
08:41AM  Bruker (BRKR) at a 52-Week High: What's Driving the Stock? Zacks
08:19AM  OPKO Health (OPK) Signs New Agreement with Japan Tobacco Zacks
Oct-12-17 09:34AM  LabCorp (LH) Strong on Strategic Planning, Competition Rife Zacks
09:00AM  DENTSPLY SIRONA Strong on Deal Renewals, Forex Woes Stay Zacks
08:51AM  Ecolab (ECL) to Divest Equipment Care Segment, Shares Fall Zacks
08:49AM  Veeva Systems (VEEV) Rides High on Commercial Cloud Platform Zacks
08:48AM  Henry Schein Closes Merritt Buyout, Expands in Animal Health Zacks
08:47AM  CryoLife to Buy JOTEC, Preliminary Revenue Result Out for Q3 Zacks
07:57AM  Mazor Projects Higher Q3 Revenues, Clinches Mazor X Orders Zacks
Oct-11-17 09:55AM  QIAGEN Banks on Tie-Ups & Product Launches, Competition Rife Zacks
09:54AM  Express Scripts (ESRX) to Buy eviCore, Fortify PBM Business Zacks
08:32AM  The Zacks Analyst Blog Highlights: IDEXX Laboratories, Steris, K2M Group Holdings, Tandem Diabetes Care and Intersect ENT Zacks
Oct-10-17 04:59PM  5 MedTech Stocks for Stellar Returns in Q3 Zacks
04:53PM  4 Top Growth Picks as MedTech Battle Rages On Zacks
09:50AM  Pacific Biosciences, Bluebee Team Up for De Novo Sequencing Zacks
09:34AM  QIAGEN Partners With CENTOGENE, Boosts Bioinformatics Suite Zacks
09:26AM  Illumina (ILMN) Strong on Product Launches, Competition Rife Zacks
09:00AM  Fresenius Medical (FMS) Well Poised on Growth Strategy 2020 Zacks
Oct-09-17 02:59PM  Boston Scientific Grows on New Products, Currency Woe Ails Zacks
09:00AM  Hurricane Maria to Hurt Medtronic in Q2, FY18 View Intact Zacks
09:00AM  DaVita Banks on Acquisitions, Escalating Expenses a Concern Zacks
08:08AM  Teleflex (TFX) Hits a 52-Week High on NeoTract Acquisition Zacks
07:01AM  Integra's (IART) Revize/Revize-X Boosts Tissue Technology Arm Zacks
Oct-06-17 10:53AM  ETFs with exposure to IDEXX Laboratories, Inc. : October 6, 2017 Capital Cube
09:41AM  Abbott (ABT) Hits a 52-Week High: What's Driving the Stock? Zacks
09:33AM  QIAGEN's QFT-Plus Launch to Boost Molecular Diagnostics Arm Zacks
09:31AM  Hologic's Panther Fusion Flu A/B/RSV Assay Gets FDA Approval Zacks
09:00AM  Masimo (MASI) Launches Trace Data and Reporting Tool in US Zacks
IDEXX Laboratories, Inc., together with its subsidiaries, develops, manufactures, and distributes products and services primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets worldwide. It operates through Companion Animal Group; Water Quality Products; Livestock, Poultry and Dairy; and Other segments. The company provides point-of-care veterinary diagnostic products, including instruments, consumables, and rapid assays; veterinary reference laboratory diagnostic and consulting services; practice management and diagnostic imaging systems and services for veterinarians; and biological materials testing, and laboratory animal diagnostic instruments and services for biomedical research community. It also offers diagnostic and health-monitoring products for livestock, poultry, and dairy markets; products that test water for various microbiological contaminants; and point-of-care electrolytes and blood gas analyzers that are used in the human point-of-care medical diagnostics market. The company markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers. IDEXX Laboratories, Inc. was founded in 1983 and is headquartered in Westbrook, Maine.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
AYERS JONATHAN WChairman, President & CEOJan 11Option Exercise38.8018,000698,3101,077,112Jan 11 06:11 PM
AYERS JONATHAN WChairman, President & CEOJan 11Sale167.032,160360,7811,074,952Jan 11 06:11 PM
AYERS JONATHAN WChairman, President & CEOJan 10Option Exercise38.8018,000698,3101,077,112Jan 11 06:11 PM
AYERS JONATHAN WChairman, President & CEOJan 10Sale164.8818,0002,967,8081,059,112Jan 11 06:11 PM
AYERS JONATHAN WChairman, President & CEOJan 09Option Exercise38.8018,000698,3101,077,112Jan 11 06:11 PM
AYERS JONATHAN WChairman, President & CEOJan 09Sale165.1518,0002,972,6301,059,112Jan 11 06:11 PM
AYERS JONATHAN WChairman, President & CEOJan 03Option Exercise38.8012,500484,9381,059,112Jan 05 06:00 PM
MCKEON BRIAN PExecutive VP & CFOJan 01Option Exercise0.002,820041,533Jan 03 05:55 PM
MAZELSKY JAYExecutive Vice PresidentDec 05Option Exercise0.00961019,355Dec 07 05:33 PM
TWIGGE GIOVANIChief Human Resources OfficerNov 30Sale156.072,000312,13714,402Dec 04 06:00 PM
AYERS JONATHAN WChairman, President & CEONov 16Option Exercise38.8018,000698,3101,064,573Nov 16 09:04 PM
AYERS JONATHAN WChairman, President & CEONov 16Sale153.6118,0002,764,9021,046,573Nov 16 09:04 PM
AYERS JONATHAN WChairman, President & CEONov 15Option Exercise38.8018,000698,3101,064,573Nov 16 09:04 PM
AYERS JONATHAN WChairman, President & CEONov 15Sale149.6118,0002,692,9541,046,573Nov 16 09:04 PM
AYERS JONATHAN WChairman, President & CEONov 14Option Exercise38.8018,000698,3101,064,573Nov 16 09:04 PM
AYERS JONATHAN WChairman, President & CEONov 14Sale148.3518,0002,670,2801,046,573Nov 16 09:04 PM
AYERS JONATHAN WChairman, President & CEONov 07Option Exercise38.7518,000697,5001,064,573Nov 07 05:31 PM
AYERS JONATHAN WChairman, President & CEONov 07Sale148.7718,0002,677,8011,046,573Nov 07 05:31 PM
AYERS JONATHAN WChairman, President & CEONov 06Option Exercise38.7518,000697,5001,064,573Nov 07 05:31 PM
AYERS JONATHAN WChairman, President & CEONov 06Sale151.4618,0002,726,2341,046,573Nov 07 05:31 PM
AYERS JONATHAN WChairman, President & CEONov 03Option Exercise38.7518,000697,5001,064,573Nov 07 05:31 PM
AYERS JONATHAN WChairman, President & CEONov 03Sale153.7518,0002,767,4131,046,573Nov 07 05:31 PM
AYERS JONATHAN WChairman, President & CEONov 02Option Exercise38.7512,500484,3751,046,573Nov 06 05:20 PM
Studer JacquelineCVP, Gen. Counsel & SecretarySep 01Option Exercise0.001,12904,704Sep 06 06:06 PM
MAZELSKY JAYExecutive Vice PresidentSep 01Option Exercise0.002,366019,535Sep 06 06:05 PM
AYERS JONATHAN WChairman, President & CEOAug 28Option Exercise38.8016,000620,7201,044,034Aug 30 06:28 PM
AYERS JONATHAN WChairman, President & CEOAug 28Sale150.7913,0001,960,2641,031,034Aug 30 06:28 PM
HENDERSON REBECCA MDirectorAug 23Sale153.712,578396,26914,696Aug 25 05:01 PM
HENDERSON REBECCA MDirectorAug 22Sale152.862,578394,07317,274Aug 25 05:01 PM
AYERS JONATHAN WChairman, President & CEOAug 16Option Exercise38.8022,000853,4901,049,034Aug 16 09:32 PM
AYERS JONATHAN WChairman, President & CEOAug 16Sale155.4720,0003,109,4881,029,034Aug 16 09:32 PM
AYERS JONATHAN WChairman, President & CEOAug 15Option Exercise38.8022,000853,4901,041,934Aug 16 09:32 PM
AYERS JONATHAN WChairman, President & CEOAug 15Sale154.6220,0003,092,3481,027,034Aug 16 09:32 PM
AYERS JONATHAN WChairman, President & CEOAug 14Option Exercise38.8020,000775,9001,043,034Aug 16 09:32 PM
AYERS JONATHAN WChairman, President & CEOAug 14Sale154.9118,0002,788,3371,025,034Aug 16 09:32 PM
AYERS JONATHAN WChairman, President & CEOAug 09Option Exercise38.8020,000775,9001,039,034Aug 10 08:20 PM
AYERS JONATHAN WChairman, President & CEOAug 09Sale154.5417,0002,627,1831,022,034Aug 10 08:20 PM
AYERS JONATHAN WChairman, President & CEOAug 08Option Exercise38.8020,000775,9001,038,034Aug 09 06:05 PM
AYERS JONATHAN WChairman, President & CEOAug 08Sale155.2218,0002,793,9601,020,034Aug 09 06:05 PM
Kingsley Lawrence DDirectorAug 03Buy151.762,000303,5173,344Aug 04 07:00 PM
TWIGGE GIOVANIChief Human Resources OfficerMay 31Sale166.902,572429,27216,332Jun 01 05:40 PM
AYERS JONATHAN WChairman, President & CEOMay 30Option Exercise38.8015,000581,9251,032,994Jun 01 05:40 PM
AYERS JONATHAN WChairman, President & CEOMay 30Sale167.8213,0002,181,6431,019,994Jun 01 05:40 PM
END WILLIAM TDirectorMay 22Sale162.555,000812,76945,256May 23 08:26 AM
AYERS JONATHAN WChairman, President & CEOMay 10Option Exercise38.8030,0001,163,8501,034,994May 11 06:01 PM
AYERS JONATHAN WChairman, President & CEOMay 10Sale162.6927,0004,392,6271,014,994May 11 06:01 PM
AYERS JONATHAN WChairman, President & CEOMay 05Option Exercise38.8030,0001,163,8501,040,994May 08 06:30 PM
AYERS JONATHAN WChairman, President & CEOMay 05Sale160.6126,0004,175,9381,014,994May 08 06:30 PM
HENDERSON REBECCA MDirectorMay 04Option Exercise38.806,602256,12521,552May 05 06:11 PM
HENDERSON REBECCA MDirectorMay 04Sale159.951,700271,91219,852May 05 06:11 PM
Kingsley Lawrence DDirectorMar 01Buy146.481,000146,4801,135Mar 02 06:01 PM
HENDERSON REBECCA MDirectorFeb 28Sale145.196,500943,72114,950Mar 06 06:44 PM
AYERS JONATHAN WChairman, President & CEOFeb 22Option Exercise39.0152,2862,039,6711,045,947Feb 23 06:12 PM
AYERS JONATHAN WChairman, President & CEOFeb 22Sale142.5835,0004,990,1351,010,947Feb 23 06:12 PM
MCKEON BRIAN PExecutive VP & CFOFeb 16Option Exercise53.191,88099,98838,548Feb 21 05:45 PM
END WILLIAM TDirectorFeb 16Sale141.715,000708,53450,256Feb 21 05:45 PM
TWIGGE GIOVANICORPORATE VICE PRESIDENTFeb 14Option Exercise0.001,703019,432Feb 16 07:23 PM
Studer JacquelineCVP, Gen. Counsel & SecretaryFeb 14Option Exercise0.0075203,769Feb 16 07:22 PM
MAZELSKY JAYExecutive Vice PresidentFeb 14Option Exercise0.002,157017,802Feb 16 07:21 PM
MCKEON BRIAN PExecutive VP & CFOFeb 14Option Exercise0.002,166037,477Feb 16 07:20 PM
AYERS JONATHAN WChairman, President & CEOFeb 14Option Exercise0.006,3340996,820Feb 16 07:20 PM
END WILLIAM TDirectorFeb 10Option Exercise38.806,602256,12555,256Feb 14 05:27 PM
JUNIUS DANIEL MDirectorFeb 08Option Exercise64.693,000194,0705,495Feb 09 05:20 PM
AYERS JONATHAN WChairman, President & CEOFeb 08Option Exercise26.6636,250966,2441,026,736Feb 09 05:21 PM
MCKEON BRIAN PExecutive VP & CFOFeb 08Option Exercise26.669,924264,52445,235Feb 09 05:21 PM
AYERS JONATHAN WChairman, President & CEOFeb 08Sale141.6336,2505,134,171990,486Feb 09 05:21 PM
JUNIUS DANIEL MDirectorFeb 08Sale141.753,000425,2642,495Feb 09 05:20 PM
MCKEON BRIAN PExecutive VP & CFOFeb 08Sale141.649,9241,405,59135,311Feb 09 05:21 PM